DiaMedica Therapeutics Stock (NASDAQ: DMAC) stock price, news, charts, stock research, profile.
Open | $2.730 |
Close | $2.770 |
Volume / Avg. | 20.761K / 42.611K |
Day Range | 2.730 - 2.810 |
52 Wk Range | 1.460 - 4.750 |
Market Cap | $102.487M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 0.62% |
Days to Cover | 7.58 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of DiaMedica Therapeutics (NASDAQ: DMAC) through any online brokerage.
There are no as such competitors for DiaMedica Therapeutics.
The latest price target for DiaMedica Therapeutics (NASDAQ: DMAC) was reported by Craig-Hallum on Thursday, March 21, 2024. The analyst firm set a price target for 8.00 expecting DMAC to rise to within 12 months (a possible 196.30% upside). 3 analyst firms have reported ratings in the last year.
The stock price for DiaMedica Therapeutics (NASDAQ: DMAC) is $2.7 last updated March 28, 2024 at 7:15 AM EDT.
There are no upcoming dividends for DiaMedica Therapeutics.
DiaMedica Therapeutics’s Q3 earnings are confirmed for Wednesday, November 9, 2022.
There is no upcoming split for DiaMedica Therapeutics.
DiaMedica Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.